We would like LDN patients to participate

[Shewulf]

We would like LDN patients to participate and for everyone to share the link. form.ldnresearchtrust.org/2...

Thank you so much for your attention and participation.

The effects of low dose Naltrexone (LDN) on diseases of aging.

A retrospective cross-sectional study into the off-label use of LDN.

Principal Investigator: Dr. Sajad Zalzala

Institute: LDN Research Trust

Sponsor: Belmar Pharmacy

Email: [e-mail]

About:

The study has been reviewed and approved by an institutional review board (IRB): The Institute of Regenerative and Cellular Medicine.

We will investigate any effects of low dose Naltrexone (LDN) on general health and aging-related diseases.

Participation and Eligibility:

Taking part in the study is voluntary and free, and you can withdraw your consent at any time or ask any questions you may have by emailing [e-mail]. No payment or reward is given.

Participants must be 18+ years, take Low Dose Naltrexone (LDN) for a diagnosed medical condition, have the legal ability to make your own decisions and complete the questionnaire only once.

Questions will include Information about your health, in the past and present, your medication use, and your family medical history. You could be asked to provide blood test results if available. The tests will look at markers for aging, immune, and general health status.

Participants will not be asked to stop or change the dosing of any your medications, including LDN.

This survey should take you less than 20 minutes to complete

Participants who are taking LDN 20+ mg per day or have terminal cancer are NOT eligible.

Purpose:

No studies have yet investigated the long-term effects of LDN use, and how it affects the general health of patients taking this medication. We aim to investigate this by assessing the health of patients using LDN for various conditions. We also aim to determine whether LDN use has prevented the use of other medications.

Benefits and Disadvantages:

There are no health benefits. Your contribution could help patients in the future and might lead to a better understanding of the health effects of LDN. There are no health risks in participating.

Confidentiality:

All Information will be stored on JotForm.com. which is password-protected and secured. Your Information will be coded with a unique anonymous identification number. Your anonymous data will be available only to researchers who have approval.

Upon two years of completion, identifiable Information will be deleted, and only the anonymous data will be stored securely.

We would like LDN patients to participate and for everyone to share the link. form.ldnresearchtrust.org/2...

Thank you so much for your attention and participation.

The effects of low dose Naltrexone (LDN) on diseases of aging.

A retrospective cross-sectional study into the off-label use of LDN.

Principal Investigator: Dr. Sajad Zalzala

Institute: LDN Research Trust

Sponsor: Belmar Pharmacy

Email: [e-mail]

About:

The study has been reviewed and approved by an institutional review board (IRB): The Institute of Regenerative and Cellular Medicine.

We will investigate any effects of low dose Naltrexone (LDN) on general health and aging-related diseases.

Participation and Eligibility:

Taking part in the study is voluntary and free, and you can withdraw your consent at any time or ask any questions you may have by emailing [e-mail]. No payment or reward is given.

Participants must be 18+ years, take Low Dose Naltrexone (LDN) for a diagnosed medical condition, have the legal ability to make your own decisions and complete the questionnaire only once.

Questions will include Information about your health, in the past and present, your medication use, and your family medical history. You could be asked to provide blood test results if available. The tests will look at markers for aging, immune, and general health status.

Participants will not be asked to stop or change the dosing of any your medications, including LDN.

This survey should take you less than 20 minutes to complete

Participants who are taking LDN 20+ mg per day or have terminal cancer are NOT eligible.

Purpose:

No studies have yet investigated the long-term effects of LDN use, and how it affects the general health of patients taking this medication. We aim to investigate this by assessing the health of patients using LDN for various conditions. We also aim to determine whether LDN use has prevented the use of other medications.

Benefits and Disadvantages:

There are no health benefits. Your contribution could help patients in the future and might lead to a better understanding of the health effects of LDN. There are no health risks in participating.

Confidentiality:

All Information will be stored on JotForm.com. which is password-protected and secured. Your Information will be coded with a unique anonymous identification number. Your anonymous data will be available only to researchers who have approval.

Upon two years of completion, identifiable Information will be deleted, and only the anonymous data will be stored securely.